articleThe LancetAug 1, 2009GREEN OA

Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials

University of Modena and Reggio Emilia · Liverpool School of Tropical Medicine · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

609
total citations
FWCI
55.56
Percentile
100%
References
35
Citations per year

Authors

7

Topics & keywords

Keywords
  • Roflumilast
  • Medicine
  • Salmeterol
  • COPD
  • Placebo
  • Tiotropium bromide
  • Bronchodilator
  • Anesthesia
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding